ImageneBio, Inc. (IMA) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-1.11x
ImageneBio, Inc. (IMA) has a Cash Flow-to-Debt Ratio of -1.11x as of March 2026, meaning its operating cash flow of $-14.80 Million could theoretically repay -1% of its total liabilities ($13.36 Million) in one year. Explore IMA long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
-1.11x
Operating CF / Total Liabilities
Operating Cash Flow
$-14.80 Million
USD
Total Liabilities
$13.36 Million
USD
Data as of
Mar 2026
Most recent filing
ImageneBio, Inc. Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for ImageneBio, Inc. across 8 annual periods. Also explore IMA asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ImageneBio, Inc. (2018–2025)
Year-by-year debt coverage analysis for ImageneBio, Inc.. For market capitalisation and broader financial context, see IMA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.41x | $-47.84 Million | $19.84 Million | ▲ +18.3% |
| 2024 | -2.95x | $-46.00 Million | $15.58 Million | ▲ +17.3% |
| 2023 | -3.57x | $-79.74 Million | $22.34 Million | ▼ -21.8% |
| 2022 | -2.93x | $-74.11 Million | $25.29 Million | ▼ -94.6% |
| 2021 | -1.51x | $-60.25 Million | $40.00 Million | ▼ -973.0% |
| 2020 | -0.14x | $-37.83 Million | $269.45 Million | ▼ -143.2% |
| 2019 | 0.33x | $47.93 Million | $147.44 Million | ▲ +286.3% |
| 2018 | -0.17x | $-11.61 Million | $66.52 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.